Status:
COMPLETED
Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction
Lead Sponsor:
Benha University
Collaborating Sponsors:
Cairo University
Conditions:
Erectile Dysfunction
Botulinum Toxin
Eligibility:
MALE
40-70 years
Phase:
PHASE2
Brief Summary
purpose: The aim of this study is to compare the safety, efficacy and durability of different doses of BTX-A (50 and 100 unit) in the treatment of Vasculogenic Erectile Dysfunction after failure of ot...
Detailed Description
introduction: Evidence has been arising suggesting that Botulinum toxin type A (BTX-A) injections can relax smooth muscles fibers in the treatment of obesity and Detrusor muscle over-activity, similar...
Eligibility Criteria
Inclusion
- Age between 40 to 70 years. Vascular ED proved by penile duplex. Unable to develop erections sufficient for intercourse. A "No" response on Sexual encounter profile questions (SEP 2 \& 3) Failing to respond to first line and second line treatments for Erectile Dysfunction with surgery as the only remaining treatment option.
Exclusion
- Significant cardiovascular disease interfering with sexual activity Any history of an unstable medical or psychiatric condition Any presence of penile anatomical abnormalities (e.g. penile fibrosis) that would significantly impair erectile function.
Key Trial Info
Start Date :
July 12 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03355963
Start Date
July 12 2016
End Date
February 20 2019
Last Update
November 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.